Back to Search Start Over

Assessing total retinal blood flow in diabetic retinopathy using multiplane en face Doppler optical coherence tomography.

Authors :
Pechauer AD
Hwang TS
Hagag AM
Liu L
Tan O
Zhang X
Parker M
Huang D
Wilson DJ
Jia Y
Source :
The British journal of ophthalmology [Br J Ophthalmol] 2018 Jan; Vol. 102 (1), pp. 126-130. Date of Electronic Publication: 2017 May 11.
Publication Year :
2018

Abstract

Aim: To assess total retinal blood flow (TRBF) in diabetic retinopathy (DR) using multiplane en face Doppler optical coherence tomography (OCT).<br />Methods: A 70 kHz spectral-domain OCT system scanned a 2×2 mm area centred at the optic disc of the eyes with DR and healthy participants. The multiplane en face Doppler OCT algorithm generated a three-dimensional volumetric data set consisting of 195 en face planes. The TRBF was calculated from the maximum flow values of each branching retinal vein at an optimised en face plane. DR severity was graded according to the international clinical classification system. The generalised linear model method was used to compare flow values between DR groups and the control group.<br />Results: A total of 71 eyes from 71 participants were included. Ten eyes were excluded due to poor image quality. The within-visit repeatability of scans was 4.1% (coefficient of variation). There was no significant difference in the TRBF between the healthy (46.7±10.2 µL/min) and mild/moderate non-proliferative DR (44.9±12.6 µL/min) groups. The TRBF in severe non-proliferative DR (39.1±12.6 µL/min) and proliferative DR (28.9±8.85 µL/min) groups were significantly lower ( p =0.04 and p <0.0001, respectively) than that of the healthy group. TRBF was correlated with DR disease severity ( p <0.0001, linear trend test).<br />Conclusion: The novel multiplane en face Doppler OCT method provided reliable measurements of TRBF in DR eyes. This may be a useful tool in understanding the pathophysiology of DR.<br />Competing Interests: Competing interests: Oregon Health & Science University (OHSU), OT, DH and YJ have a significant financial interest in Optovue, a company that may have a commercial interest in the results of this research and technology. OT and DH have a significant financial interest in Carl Zeiss Meditec. These potential conflicts of interest have been reviewed and managed by OHSU.<br /> (© Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted.)

Details

Language :
English
ISSN :
1468-2079
Volume :
102
Issue :
1
Database :
MEDLINE
Journal :
The British journal of ophthalmology
Publication Type :
Academic Journal
Accession number :
28495904
Full Text :
https://doi.org/10.1136/bjophthalmol-2016-310042